4/2
Perelman School of Medicine
Cost of End-of-Life Care in the U.S. is Comparable to Europe and Canada, Finds New Penn Study
Despite widespread perception, the United States does not provide the worst end-of-life care in the world.
Finding the Needle in a Microbial Haystack: Penn Researchers Test New Pathogen Detection Technology
Patients who are undergoing treatment for diseases such as cancer often face the added challenge of a compromised immune system, which can be a toll both of their condition and the drugs used to treat it, leaving them vulnerable to various opportunistic infections.
Penn Study Suggests New Recommendations to Reduce Radiation Risk from Digital Screening Mammography
Radiation-induced breast cancer risk from digital mammography is low for the majority of women, but risk is higher in women with large breasts, who received 2.3 times more radiation and required more views per examination to image as much of the breast as possible compared to those with small or average-sized breasts.
Health Warning Labels May Deter Parents from Purchasing Sugar-Sweetened Beverages for Kids, Penn Study Shows
Health warning labels similar to those found on tobacco products may have a powerful effect on whether parents purchase sugar-sweetened beverages (SSB) for their children, according to a new study led by the Perelman School of Medicine at the University of Pennsylvania.
Penn Science Café Presents ‘Friendship and Your Brain’
WHO: Michael Platt Penn Integrates Knowledge Professor James S. Riepe University Professor of NeurosciencePerelman School of Medicine
Penn Resource Offers Insight Into American Language, Slang and Culture
When Shiho Nagai began attending the informal, not-for-credit slanguage sessions at the University of Pennsylvania’s Christian Association, she had in mind improving her English skills.
Anti-inflammatory Drug and Gut Bacteria Have a Dynamic Interplay, According to Penn Animal Study
A nonsteroidal anti-inflammatory drug (NSAID) changed the composition and diversity of gut microbes, which in turn shaped how the drug is broken down and ultimately, cut its effectiveness, according to an animal study from the Perelman School of Medicine at the University of Pennsylvania.
Penn’s Grossman Receives Special Recognition Award for Dedication to the Disability Community
Murray Grossman, MD, EdD, a professor of Neurology in the Perelman School of Medicine at the University of Pennsylvania and director of Penn’s Frontotemporal Degeneration (FTD) Center, recently received the Legal Clinic for the Disabled's
Penn-led Team Reprograms Social Behavior in Carpenter Ants Using Epigenetic Drugs
In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.
New Breast Cancer Drug May be Effective against Other Types of Cancer, Abramson Cancer Center Experts Find
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the
In the News
Scholars at risk in their own countries find a new home at Penn
Penn Global’s Scholars-at-Risk program is featured. Global’s Ezekiel J. Emanuel and Scott Moore, Penn Carey Law’s Eric Feldman, and Wharton’s Jesús Fernández-Villaverde, along with former and current scholars Angel Alvarado, Pavel Golubev, and Jawad Moradi are interviewed.
FULL STORY →
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
FULL STORY →
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
FULL STORY →
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
FULL STORY →
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
FULL STORY →